233 related articles for article (PubMed ID: 7700928)
1. Hematopoietic progenitor cell content of bone marrow harvests: relative contributions of blood and bone marrow.
Glasser L; Fiederlein RL; Wood M; Dalton WS; List A
Prog Clin Biol Res; 1994; 389():621-30. PubMed ID: 7700928
[No Abstract] [Full Text] [Related]
2. Regulatory activity of endogenous MIP-1 alpha in long-term cultures of human marrow.
Cashman JD; Eaves AC; Wolpe S; Eaves CJ
Prog Clin Biol Res; 1994; 389():261-8. PubMed ID: 7700910
[No Abstract] [Full Text] [Related]
3. Selection of BCR/ABL-negative progenitor cells from chronic myeloid leukemia marrow.
Leemhuis T; Leibowitz D; Cox G; Srour EF; Tricot G; Hoffman R
Prog Clin Biol Res; 1992; 377():231-7. PubMed ID: 1279706
[No Abstract] [Full Text] [Related]
4. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia.
Betticher DC; Huxol H; Müller R; Speck B; Nissen C
Exp Hematol; 1993 Nov; 21(12):1517-21. PubMed ID: 8405233
[TBL] [Abstract][Full Text] [Related]
5. A manual method for processing bone marrow using percoll: characteristics of the transfusion product.
Glasser L; Smith DM; Fiederlein RL; Wood M
Prog Clin Biol Res; 1994; 389():685-94. PubMed ID: 7700936
[No Abstract] [Full Text] [Related]
6. [Autologous bone marrow transplantation for patients with chronic myelogenous leukemia after in vitro purging of the graft with bcr/abl antisense oligodeoxynucleotides].
Sun J; Wu B; Liu Q; Feng R; Liu X; Meng F; Zhou S
Zhonghua Xue Ye Xue Za Zhi; 2000 Aug; 21(8):400-2. PubMed ID: 11877009
[TBL] [Abstract][Full Text] [Related]
7. Mononuclear and CD34+ stem cell recovery after automated Ficoll processing of marrow or peripheral blood stem cells for transplantation.
Cottler-Fox M; Read EJ; Yu M; Carter C; Klein HG
Prog Clin Biol Res; 1992; 377():569-73. PubMed ID: 1279726
[No Abstract] [Full Text] [Related]
8. Processing of bone marrow for transplantation: development of a mononuclear cell enrichment protocol.
Hollingsworth KL; Williams SF; Blake MS; Pothiawala M; Mick R; Larson RA; Bender JG
Prog Clin Biol Res; 1994; 389():695-704. PubMed ID: 7700937
[No Abstract] [Full Text] [Related]
9. Yield of primed progenitor cells as determined by days of priming with recombinant human granulocyte-colony stimulating factor.
Ericson SG; Meehan KR; Tosteson TD; Mills LE
Prog Clin Biol Res; 1994; 389():449-55. PubMed ID: 7535453
[No Abstract] [Full Text] [Related]
10. Detection of bcr-abl mRNA in single progenitor colonies from patients with chronic myeloid leukemia by PCR: comparison with cytogenetics and PCR from uncultured cells.
Schulze E; Krahl R; Thalmeier K; Helbig W
Exp Hematol; 1995 Dec; 23(14):1649-54. PubMed ID: 8542960
[TBL] [Abstract][Full Text] [Related]
11. Comparative assays of megakaryocyte progenitors in CD34+ peripheral blood progenitor cell fractions.
Petsche D; Hami L; Purdy M; Myers S; Hogan C; Messner H; Briddell R; Heimfeld S; Berenson R; Shpall E
Prog Clin Biol Res; 1994; 389():415-20. PubMed ID: 7535450
[No Abstract] [Full Text] [Related]
12. Component processing and intraoperative autotransfusion during bone marrow harvest.
Cook-Craig A; Owen A; Reeder G; Drobyski W; Horowitz M; Brunner J; Flomenberg N; Keever C
Prog Clin Biol Res; 1994; 389():613-9. PubMed ID: 7700927
[No Abstract] [Full Text] [Related]
13. BCR/ABL-negative clonogenic hematopoietic cells do not accumulate in the plastic-adherent fraction of peripheral blood mononuclear cells from patients with chronic myeloid leukemia in stable chronic phase.
Schultheis B; Pasternak G; Hehlmann R
Folia Biol (Praha); 2000; 46(6):256-63. PubMed ID: 11140859
[TBL] [Abstract][Full Text] [Related]
14. Preferential sequestration in vitro of BCR/ABL negative hematopoietic progenitor cells among cytokine nonresponsive CML marrow CD34+ cells.
Veena P; Cornetta K; Davidson A; Agüero B; McMahel J; Traycoff CM; Srour EF
Bone Marrow Transplant; 1997 Jun; 19(12):1213-21. PubMed ID: 9208115
[TBL] [Abstract][Full Text] [Related]
15. Deficient reconstitution of early progenitors after allogeneic bone marrow transplantation.
Podestà M; Piaggio G; Frassoni F; Pitto A; Mordini N; Bregante S; Valeriani A; Bacigalupo A
Bone Marrow Transplant; 1997 May; 19(10):1011-7. PubMed ID: 9169645
[TBL] [Abstract][Full Text] [Related]
16. Potent antileukemic activity of the novel agents norsegoline and dibezine.
Einat M; Nagler A; Lishner M; Amiel A; Yarkoni S; Rudi A; Gellerman G; Kashman Y; Fabian I
Clin Cancer Res; 1995 Aug; 1(8):823-9. PubMed ID: 9816051
[TBL] [Abstract][Full Text] [Related]
17. Evaluating efficiency of bone marrow harvest and its manipulation--role of CD 34 positivity.
Parikh PM; Badrinath Y; Dhond S; Kulkarni S; Dhar AK; Raje N; Saikia TK; Bharbhaya S; Gopal R; Kurkure PA
J Assoc Physicians India; 1995 Jul; 43(7):470-2. PubMed ID: 8713220
[TBL] [Abstract][Full Text] [Related]
18. Mobilization of peripheral blood stem cells: comparing cyclophosphamide and growth factor based regimens.
Janssen WE; Smilee R; Carter R; Rahn D; Cairo M; Hiemenz JH; Zorsky PE; Fields KK; Ballester O; Perkins J
Prog Clin Biol Res; 1994; 389():429-39. PubMed ID: 7700915
[No Abstract] [Full Text] [Related]
19. Long-lasting decrease of marrow and circulating long-term culture initiating cells after allogeneic bone marrow transplant.
Selleri C; Maciejewski JP; De Rosa G; Raiola A; Risitano AM; Picardi M; Pezzullo L; Luciano L; Ricci P; Varriale G; Della Cioppa P; Del Vecchio L; Rotoli B
Bone Marrow Transplant; 1999 May; 23(10):1029-37. PubMed ID: 10373069
[TBL] [Abstract][Full Text] [Related]
20. Two consecutive courses of rh-G-CSF-mobilized peripheral blood stem cells for primary marrow alloengraftment failure: case report.
Martino M; Pucci G; Irrera G; Messina G; Morabito F; Iacopino P
Haematologica; 1996; 81(5):464-7. PubMed ID: 8952162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
